Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gerson is a privately held U.S. manufacturer of respiratory protection products and other disposable industrial consumables sold under the Gerson brand. The company was founded in 1956 and today operates from Middleboro, Massachusetts, where it manufactures products including N95, N99, R95, and P100 respirators, reusable half-mask and full-face respirators, cartridge filters, and related PPE kits. In addition to healthcare-adjacent respiratory products, Gerson also produces paint strainers, tack cloths, and surface-preparation consumables for industrial and automotive markets. The company emphasizes vertically integrated, automated manufacturing using proprietary equipment, including U.S.-made melt-blown filtration media for certain respirator lines. Gerson appears to be a commercial-stage operating company rather than a therapeutic biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gerson.